number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide New weight-loss drugs surge in popularity amid obesity surge in US, worldwide Lilly weight-loss drug Zepbound new

Clinical trials have shown that patients can lose up to 15% of their body weight over a 12- to 16-month period, with some individuals experiencing more rapid weight loss in the early stages of treatment

Fewer side effects mean a more comfortable experience, but they may also mean less drug is reaching systemic circulation to produce therapeutic effects

This helps prepare your review and match your preferences with available options

For injectable tirzepatide, we have evidence from multiple Phase III clinical trials involving over 10,000 participants, published in the New England Journal of Medicine, The Lancet, and JAMA

If you are unhappy with your results, let us know and well make it right